ABOUT THE PCR MITRAL FOCUS GROUP
The mission of this Focus Group is to promote innovation and improve adaptation by increasing understanding of disease, advancing therapeutic standards based on phenotypes, and developing tools to address unmet needs, while aligning knowledge, standardising practice, and facilitating collaboration among physicians and associations.
Launched in 2025, the PCR Mitral Focus Group is dedicated to making mitral valve disease easier to understand and manage. By uniting specialists across disciplines, it aims to clarify patient selection, support education, and bring consistency to both established and emerging therapies.
Introducing the team behind the PCR Mitral Focus Group
A multidisciplinary Core Team
The Focus Group Directors are both focused on advancing structural heart interventions, with Philipp Lurz working as an Interventional Cardiologist, and Thomas Modine as a Cardiac and Interventional Surgeon.
They are joined by 42 experts, including Cardiologists, Cardiac surgeons, Imaging specialists, Heart failure specialists, Innovators, Strategists, and Electrophysiologists (EP), all assigned to one of five working groups:
- Anatomy and Imaging
- Innovations
- Interventions
- Evidence
- Therapy adoption
